[Currently used therapeutic agents for arteriosclerosis--with special reference to a protein anabolic hormone, clofibrate (C.P.I.B.)].
D045930:Anabolic Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy*; D002994:Clofibrate / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D005227:Fatty Acids / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010743:Phospholipids / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use*; D012256:Riboflavin / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use
D045930:Anabolic Agents; D000728:Androgens; D000924:Anticholesteremic Agents; D003911:Dextrans; D005227:Fatty Acids; D010743:Phospholipids; D011422:Propionates; D006493:Heparin; D002994:Clofibrate; D013974:Thyroxine; D012256:Riboflavin